Ionis Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.10.17	Ionis Pharmaceuticals Announces Plans to Open Expanded Access Program to Provide Inotersen to Patients with Hereditary TTR Amyloidosis in the U.S. (PR Newswire)
25.10.17	ATOS Catches Eyes, PTIE Gains, CNCE Hits Right Notes, SMMT Keeps Sliding (RTTNews)
24.10.17	NuVasive Announces $100 Million Share Repurchase Program (PR Newswire)
24.10.17	Ionis Pharmaceuticals to Hold Third Quarter 2017 Financial Results Webcast (PR Newswire)
18.10.17	Ionis Enters into Collaboration with Seventh Sense Biosystems to Support Development of Improved Blood Collection and Diagnostic Device (PR Newswire)
15.10.17	Ionis Presents New Data from NEURO-TTR Study and Highlights Programs from Its Neurological Disease Franchise at ANA Congress (PR Newswire)
13.10.17	Ionis Pharmaceuticals Initiates Clinical Study of IONIS-MAPT Rx in Patients with Alzheimer's Disease (PR Newswire)
11.09.17	New Data Presented at European Society for Medical Oncology Meeting Demonstrate Antitumor Activity with IONIS-STAT3-2.5 Rx in Combination with Imfinzi (PR Newswire)
05.09.17	Tailored Brands Provides Hurricane Harvey Relief (PR Newswire)
30.08.17	2018 Hyundai Sonata Earns 2017 IIHS TOP SAFETY PICK+ Award (PR Newswire)
30.08.17	Ionis Earns $40 Million SPINRAZA Regulatory Milestone Payment from Biogen (PR Newswire)
24.08.17	Ionis Recommends Shareholders Reject The Below-The-Market Mini-Tender Offer By TRC Capital Corporation (PR Newswire)
23.08.17	Technical Snapshots for These Drug Makers Stocks -- Teva Pharma, Endo, Ionis Pharma, and Amarin (PR Newswire)
17.08.17	Ionis Pharmaceuticals to Present at Upcoming Investor Conferences (PR Newswire)
11.08.17	Ionis Retains All Rights To Inotersen, IONIS-FB-L Rx; GSK Declines Its Options (RTTNews)
11.08.17	Ionis to Independently Advance Inotersen and IONIS-FB-L Rx (PR Newswire)
08.08.17	Ionis Provides Improved 2017 Guidance Following Strong Financial Performance (PR Newswire)
27.07.17	Akcea and Ionis Announce Submission of Marketing Authorization Application for Volanesorsen to the European Medicines Agency (PR Newswire)
26.07.17	Gainers & Losers Of July 25: FLKS, MYOK, SYRS, PCRX, RETA... (RTTNews)
25.07.17	Ionis Pharmaceuticals to Hold Second Quarter 2017 Financial Results Webcast (PR Newswire)
19.07.17	Akcea Therapeutics Announces Closing of Initial Public Offering (PR Newswire)
18.07.17	Technical Reports on Drug Makers Equities -- Teva Pharma, Endo, Ionis Pharma, and Amarin (PR Newswire)
17.07.17	Ionis Earns $10 Million Milestone Payment from Biogen for Advancing a New Program in its Neurology Collaboration (PR Newswire)
14.07.17	Akcea Therapeutics Announces Pricing of Initial Public Offering (PR Newswire)
11.07.17	New Data Reveal Hidden Burden of Familial Chylomicronaemia Syndrome (FCS) (PR Newswire)
10.07.17	New Data Presented at Peripheral Nerve Society Meeting Further Support Potential Benefit of Inotersen (PR Newswire)
28.06.17	Honey Sweetie Acres and Pound Ridge Organics are newest farms to join the Certified Humane® Program (PR Newswire)
22.06.17	Enrollment in Phase 1/2a Study of IONIS-HTT Rx in Patients with Huntington's Disease Completed and Open-Label Extension Study to Open in 2H 2017 (PR Newswire)
20.06.17	Akcea Therapeutics Launches Proposed Initial Public Offering (PR Newswire)
15.06.17	Technical Snapshots for These Drug Makers Stocks -- Endo, Teva Pharma, Ionis Pharma, and Amarin (PR Newswire)
01.06.17	SPINRAZA® (nusinersen) Approved in the European Union (PR Newswire)
25.05.17	Akcea Announces Publication in The New England Journal of Medicine of Data with AKCEA-ANGPTL3-L Rx Showing Favorable Cardiometabolic Effects (PR Newswire)
16.05.17	AKBA Abuzz, ANTH On Track For RESULT, IMUC Faces Cash Crunch, IONS Falls (RTTNews)
15.05.17	Ionis Pharmaceuticals Posting Steep Loss In Afternoon Trading (RTTNews)
11.05.17	Ionis Pharmaceuticals Provides Corporate Update at 2017 Annual Meeting of Stockholders (PR Newswire)
10.05.17	Ionis Pharmaceuticals to Present at Bank of America Merrill Lynch 2017 Healthcare Conference (PR Newswire)
09.05.17	Ionis Reports Financial Results and Highlights for First Quarter 2017 (PR Newswire)
04.05.17	Drug Makers Stocks Under Scanner -- Teva Pharma, Endo, Ionis Pharma, and Amarin (PR Newswire)
26.04.17	Ionis Pharmaceuticals to Hold First Quarter 2017 Financial Results Webcast (PR Newswire)
18.04.17	Ionis Enters into Collaboration with Ribo to Advance RNA-Targeted Therapeutics in China (PR Newswire)
30.03.17	Akcea Initiates Phase 2 Study of AKCEA-APO(a)-L Rx in Patients with High Lp(a) and Cardiovascular Disease (PR Newswire)
29.03.17	Ionis Pharmaceuticals to Present at Needham Healthcare Conference (PR Newswire)
28.03.17	Akcea Therapeutics Announces Three Additions to Board of Directors (PR Newswire)
27.03.17	Akcea Therapeutics Files Registration Statement for Proposed Initial Public Offering (PR Newswire)
27.03.17	Drug Makers Stocks Under Scanner -- Teva Pharma, Endo, Ionis Pharma, and Amarin (PR Newswire)
25.03.17	Lifshitz & Miller LLP Announces Investigation of Air Methods Corporation, Fortress Investment Group LLC, Galena Biopharma, Inc., Ionis Pharmaceuticals, Inc., LMI Aerospace, Inc., Lumos Networks Corp. (PR Newswire)
16.03.17	What's In Store For AVXS Today? (RTTNews)
06.03.17	Akcea and Ionis Announce Positive Results from Pivotal Study of Volanesorsen in Patients with Familial Chylomicronemia Syndrome (FCS) (PR Newswire)
05.03.17	What Awaits These 10 Biotech Stocks In March? (RTTNews)
03.03.17	Learn how to target a 58% return on AveXis Inc., or get option-trade ideas on Ionis Pharmaceuticals, The Medicines Co, Prothena and Tesaro Inc. or any stock you choose (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

15.11.24		Schwacher Handel in New York: NASDAQ Composite verbucht zum Handelsende Abschläge
10.09.24		Dienstagshandel in New York: NASDAQ Composite zum Ende des Dienstagshandels auf grünem Terrain
10.09.24		Pluszeichen in New York: Anleger lassen NASDAQ Composite am Nachmittag steigen
10.09.24		Schwacher Handel: So entwickelt sich der NASDAQ Composite aktuell
10.09.24		Freundlicher Handel: NASDAQ Composite startet im Plus
30.08.24		Börse New York in Grün: NASDAQ Composite beendet die Sitzung im Plus
27.08.24		Optimismus in New York: NASDAQ Composite liegt schlussendlich im Plus
22.07.24		Freundlicher Handel in New York: NASDAQ Composite notiert zum Handelsstart im Plus

15.11.24

Schwacher Handel in New York: NASDAQ Composite verbucht zum Handelsende Abschläge

10.09.24

Dienstagshandel in New York: NASDAQ Composite zum Ende des Dienstagshandels auf grünem Terrain

10.09.24

Pluszeichen in New York: Anleger lassen NASDAQ Composite am Nachmittag steigen

10.09.24

Schwacher Handel: So entwickelt sich der NASDAQ Composite aktuell

10.09.24

Freundlicher Handel: NASDAQ Composite startet im Plus

30.08.24

Börse New York in Grün: NASDAQ Composite beendet die Sitzung im Plus